US6506816B1 - Dental resin cements having improved handling properties - Google Patents

Dental resin cements having improved handling properties Download PDF

Info

Publication number
US6506816B1
US6506816B1 US08/896,549 US89654997A US6506816B1 US 6506816 B1 US6506816 B1 US 6506816B1 US 89654997 A US89654997 A US 89654997A US 6506816 B1 US6506816 B1 US 6506816B1
Authority
US
United States
Prior art keywords
dental resin
resin cement
cement material
polymeric
shear rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/896,549
Other languages
English (en)
Inventor
Paula D. Ario
Steven M. Aasen
Brian N. Holmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/896,549 priority Critical patent/US6506816B1/en
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority to JP2000502747A priority patent/JP2001510146A/ja
Priority to AU55161/98A priority patent/AU5516198A/en
Priority to PCT/US1997/022182 priority patent/WO1999003444A1/en
Priority to EP97951546A priority patent/EP0998252B1/en
Priority to CA002295502A priority patent/CA2295502A1/en
Assigned to MINNESOTA MINING AND MANUFACTURING COMPANY reassignment MINNESOTA MINING AND MANUFACTURING COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AASEN, STEVEN M., ARIO, PAULA D., HOLMES, BRIAN D.
Assigned to 3M INNOVATIVE PROPERTIES COMPANY reassignment 3M INNOVATIVE PROPERTIES COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MINNESOTA MINING AND MANUFACTURING COMPANY
Priority to US10/315,505 priority patent/US6939900B2/en
Application granted granted Critical
Publication of US6506816B1 publication Critical patent/US6506816B1/en
Priority to JP2009192168A priority patent/JP5080538B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Definitions

  • This invention relates to dental cements. More specifically, this invention relates to dental resin cements having surprising handling characteristics.
  • Resin cements are utilized primarily for aesthetic bonding of aesthetic indirect appliances such as veneers, inlays, onlays, crowns and bridges. Resin cements generally provide excellent physical properties such as high compressive and tensile strength and low wear resistance, and are often used for bonding in difficult indirect bonding situations such as non-parallel or short crown preps.
  • Handling characteristics of currently commercially available resin luting cements for indirect appliances can cause difficulty in seating for indirect appliances due to resistance, clean-up difficulties due to low viscosity or shear dependence, fast or slow setting characteristics or stringiness.
  • the correlation value of the material to this curve is greater than 0.85 for both the increasing and decreasing shear rate curves, and the value of B is less than about ⁇ 0.01.
  • Resin cements are also provided that comprise acid functionality and water, but which do not comprise an acid reactive filler. Such cements may be self etching, thereby avoiding the need to carry out a separate acid etch step.
  • FIG. 1 shows a Viscosity vs Shear Rate Curve of a composition of the present invention.
  • Glass ionomer compositions possess excellent handling properties and can be easy to clean up after application in the oral environment, but are not as strong, have poor aesthetics, and have limited utility for certain bonding applications.
  • Commercially available resin cements in contrast, are strong, but are difficult to clean up during and after setting, and are not easily applied to the surfaces to be bonded. Clean up is the process of wiping, scraping or otherwise removing excess cement once a prefabricated prosthetic is placed in its tooth preparation.
  • the resin cements of the present invention have little to no resistance when placing a prefabricated prosthetic appliance. Cement clean-up is easier because there is little to no flow due to gravity once a prefabricated prosthetic device containing cement is seated. The cement is less stringy and messy, which makes placement onto or into a prefabricated prosthetic device easier. The cement is also brushable for ease of application, especially for use as a filled adhesive to bond restoratives. The cement also exhibits a moussy behavior on a mix pad before and after spatulation when other resin cements become runny after mixing. Cements containing handling modifier have a longer time period between work and set time than comparable resins not having a handling modifier. Longer set times may provide a more easily usable cement material because the practitioner has adequate time to ensure proper placement of the prosthetic device in the oral environment before cure of the cement, and the cement is less rigid and brittle at clean up.
  • resin cements are cements that are resin-based filled compositions that do not utilize water in its chemistry for curing.
  • a resin cement does not contain a reactive filler, an acidic functionality and water at the same time, although a resin cement according to the present invention may contain any two of these three materials in the same composition.
  • glass ionomer cements which utilize an ionomeric reaction to “set” the cement and require the presence of water to enable a reaction between acid functionalities and an acid-reactive glass.
  • the term “substantially free of added water” means that the composition does not contain water that is intentionally added as a non-complexed or coordinated entity. It is understood that many materials, such as metals or glasses, contain water that is taken up from the atmosphere or is present as a coordination complex in its normal state. Water taken up by hygroscopic materials or present as a hydrate is permissibly present in the compositions described herein. Any water that is present in the composition, regardless of source, should not be present in amounts such that the water will have a deleterious effect of the long term properties of the composition. For example, water should not be present in an amount that would facilitate reaction of any acid-reactive filler, if present, with any acidic component, if present, so that lumpiness or graininess of the material or degradation of initiators develops during commercially required storage time.
  • the components are selected such that B is less than about ⁇ 0.1, and more preferably B is between about ⁇ 0.1 and ⁇ 1.1.
  • Preferred dental cements are prepared by selection of materials such that A is greater than 10 and less than 3000, more preferably wherein A is greater than 15 and less than 1000, and most preferably wherein A is greater than 20 and less than 500.
  • the viscosity of the dental materials described herein is measured at 25° C. ⁇ 1° C. using a parallel plate controlled-stress or controlled strain rheometer. Because the measurements characterize a curve, good agreement has been found in the characterization of all materials regardless of the use of different equipment or slightly different plate diameter, use of sandpaper on the plate surface, or varying time between measurements.
  • the viscosity is measured using a Bohlin CS50 rheometer (Bohlin Instruments, NJ) with controlled stress at 25° C.
  • the plate diameter was 20 mm, the separation between the plates was 1 mm, and the plates were sometimes lined with PSA-backed sandpaper (9 micrometer abrasive particle size) to prevent the material from slipping at the plate surface.
  • the shear rate was ramped up from 0.5 to 20 sec ⁇ 1 and in reverse rate down to 0.5 from 20 sec ⁇ 1 .
  • This shear rate ramping took place every 40 or 60 seconds, with a 20 or 30 second delay time and 20 or 30 s integration time, for a total of 45 logarithmically-spaced shear rate steps per run (a run being defined as both increasing and decreasing shear direction).
  • the viscosity is measured using a Rheometric Dynamic Analyzer (Rheometrics, Inc., NJ) with controlled strain 26° C.
  • the plate diameter was 25 mm, the separation between the plates was 1 mm, and the plates were sometimes lined with PSA-backed sandpaper (9 micrometer abrasive particle size) to prevent the material from slipping at the plate surface.
  • the shear rate was ramped up from 0.4 to 25 sec ⁇ 1 and in reverse rate down to 0.4 from 25 sec ⁇ 1 . This shear rate ramping took place every 40 seconds, with a 20 second delay time and a 20 second integration time, for a total of 10 logarithmically-spaced shear rate steps when ramped up or down.
  • Correlation of the datapoints to the curve is determined using standard curve-fitting analysis techniques, such as DeltaGraph version 2.0 graphing software.
  • Dental resin cements must be evaluated for exhibition of the above properties that will exhibit their observed properties under conditions of use.
  • the skilled practitioner in the dental arts will recognize when a commercial material exhibits such properties through the ease of use of the product, i.e. the product will be of a moussy consistency, yet easily applied in a brushable format in a reversible manner such that once it is mixed or brushed it does not remain runny, but returns to its original moussy texture. Numerically demonstrating this characteristic may be difficult, because off-the-shelf products may contain polymerization initiators that will begin the cure process once the product is presented in its final use format. In the laboratory, the product development technician may easily evaluate proposed cement compositions by merely leaving out the polymerization initiator.
  • Two part mixtures are preferably evaluated by testing each part separately to determine the characteristics of the viscosity/shear curve. If one side of a two-part mixture exhibits the power law model behavior, it is very likely that the combination of parts will exhibit this behavior as well. Quantitative testing can be carried out on the mixed product, however a qualitative evaluation of the behavior of the final product should be sufficient to confirm that the final product achieves the desired behavior described herein. If the product has a sufficiently long time before polymerization, tests may be carried out as long as permitted before significant viscosity changes occur to the cement through the polymerization process. For example, many commercial resin cements identify the working time of their cements, and the time available before significant viscosity changes will be noticed.
  • Rheometer measurements may be taken on such materials until such viscosity increases affect the evaluation process, e.g. the first two minutes after mixing of a two part resin cement.
  • Such a testing protocol may be required where the cement is provided as a powder/liquid two part material, and the viscosity behavior as taught herein is not evident until the parts are mixed.
  • the dental resin cement materials of the present invention comprise a polymeric handling modifier that is dispersed in the polymerizable resin at 25° C. and that has a molecular weight greater than about 500, and preferably between about 500 and 100,000.
  • the handling modifier will be considered to be dispersed in the resin if upon visual inspection by the unassisted eye one cannot discern more than one phase.
  • Heating or other mixing techniques may be utilized to assist incorporation of the handling modifier into the resin matix, provided that upon return of the material to storage and use conditions, the handling modifier does not separate from the resin matrix.
  • Many oligomers or polymers do not disperse adequately in the resin system, and therefore are not suitable as handling modifiers.
  • An example of a polymer that is not suitable for methacrylate-based systems is paraffin wax, which does not disperse in traditionally preferred resin systems conventionally used in dental materials.
  • the identification of suitable handling modifiers must be confirmed on a case-by-case basis utilizing the guidelines provided herein.
  • the handling modifier is a polymer having a molecular weight between about 500 and 50,000, and most preferably between about 700-20,000. While no specific functionality is required on the compound to be used as the handling modifier, the presence of certain functionalities may assist in the dispersibility of the handling modifier by compatiblizing the modifier compound with the resin matrix. For example, it may be beneficial to provide polar functionalities or polymerizable functionalites in order to more easily disperse the handling modifier. The incorporation of polymerizable functionalities on the handling modifier that react using the same mechanism as the polymerizable resin additionally provides benefit in that the handling modifier would then react with the resin matrix. Leeching or loss of modifier from the ultimately cured material may thereby be avoided. Further, the matrix may also benefit from added strength or lack of weak points due to unreacted modifier.
  • the handling modifier may alternatively or additionally be provided with acidic functionality. Such functionality may assist in dispersion of the handling modifier in the resin, and may also provide an etching action on the tooth structure, thereby providing a self-etching dental cement, or a cement that does not require a separate primer or adhesive to provide high adhesion to a tooth structure.
  • the acidic group is preferably selected from oxyacids or thio-oxy acids of B, C, N, S, P. More preferably, the acidic component is a compound that is an acid of C or P.
  • a precursor to the acid such as an acid anhydride, e.g., 4-Methacryloxyethyl Trimellitate Anhydride (4META), or ester can be used in place of the acid itself, e.g., to generate the desired acid in situ.
  • Suitable acids include, carboxylic acids, sulfonic acids, and phenols, with carboxylic acids, alkylsulfonic acids, arylsulfonic acids, phosphoric, phosphinic and phosphonic acids being preferred.
  • the handling modifier is selected from the group consisting of methacrylate modified polycaprolactonediols, polycaprolactonediols (i.e., polycaprolactones), methacrylate modified polyethylene glycols, polyethylene glycol methyl ethers, methacrylate modified polytetramethylene oxides, polytetramethylene oxides, N-polyvinyl pyrrolidones (i.e., N-polyvinyl pyrrolidinones), polymeric ethoxylated Bisphenol A dimethacrylates (Bis-EMA), dicarboxy terminated polybutadienes, hydroxyl endcapped polybutadienes, and copolymers of Bisphenol A and epichlorohydrin.
  • methacrylate modified polycaprolactonediols i.e., polycaprolactones
  • methacrylate modified polyethylene glycols polyethylene glycol methyl ethers
  • the handling modifier may be the same compound as the polymerizible resin as a whole.
  • a particularly preferred cement comprises ethoxylated bisphenol A as the only polymerizable component or the major polymerizable component of the cement.
  • the preferred ethoxylated bisphenol A is a reaction product of 6 moles of ethylene oxide and one mole of bisphenol-A, which in turn is reacted with 2 moles of methacrylic acid.
  • the handling modifier is present as less than 20% by weight of the dental material, or more preferably as less than 10% of the dental material.
  • Fillers may be selected from one or more of any material suitable for incorporation in compositions used for medical applications, such as fillers currently used in dental restorative compositions and the like.
  • the filler is finely divided and preferably has a maximum particle diameter less than about 10 micrometers and an average particle diameter less than about 3.0 micrometers. More preferably, the filler has a maximum particle diameter less than about 2.0 micrometers and an average particle size of diameter less than about 0.6 micrometer.
  • the filler can have a unimodal or polymodal (e.g., bimodal) particle size distribution.
  • the filler can be an inorganic material. It can also be a crosslinked organic material that is insoluble in the polymerizable resin, and is optionally filled with inorganic filler.
  • the filler should in any event be non-toxic and suitable for use in the mouth.
  • the filler can be radiopaque, radiolucent or non-radiopaque.
  • suitable inorganic fillers are naturally-occurring or synthetic materials such as quartz, nitrides (e.g., silicon nitride), glasses derived from, for example Ce, Sb, Sn, Zr, Sr, Ba and Al, colloidal silica, feldspar, borosilicate glass, kaolin, talc, titania, and zinc glass; low Mohs hardness fillers such as those described in U.S. Pat. No.
  • submicron silica particles e.g., pyrogenic silicas such as the “Aerosil” Series “OX 50”, “130”, “150” and “200” silicas sold by Degussa and “Cab-O-Sil M5” silica sold by Cabot Corp.
  • suitable organic filler particles include filled or unfilled pulverized polycarbonates, polyepoxides, and the like.
  • Preferred non-acid reactive filler particles are quartz, submicron silica, and non-vitreous microparticles of the type described in U.S. Pat. No. 4,503,169. Mixtures of these non-acid reactive fillers are also contemplated, as well as combination fillers made from organic and inorganic materials.
  • the surface of the filler particles is treated with a coupling agent in order to enhance the bond between the filler and the polymerizable resin.
  • suitable coupling agents include gamma-methacryloxypropyltrimethoxysilane, gamma-mercaptopropyltriethoxysilane, gamma-aminopropyltrimethoxysilane, and the like.
  • Reactive fillers may be included compositions of the present invention, which may or may not have the property of releasing fluoride.
  • Such fillers include those that are commonly used with ionomers to form ionomer cements.
  • suitable reactive fillers include metal oxides such as zinc oxide and magnesium oxide, and ion-leachable glasses, e.g., as described in U.S. Pat. Nos. 3,655,605; 3,814,717; 4,143,018; 4,209,434; 4,360,605 and 4,376,835.
  • Such reactive fillers may be incorporated to modify the handling characteristics or to affect the setting properties of the ultimate composition.
  • the reactive filler is preferably a finely divided reactive filler.
  • the filler should be sufficiently finely-divided so that it can be conveniently mixed with the other ingredients and used in the mouth.
  • Preferred average particle diameters for the filler are about 0.02 to about 15 micrometers, more preferably about 0.02 to 10 micrometers, as measured using, for example, a sedimentation analyzer.
  • Suitable acid-reactive fillers include metal oxides, metal salts and glasses.
  • Preferred metal oxides include barium oxide, calcium oxide, magnesium oxide and zinc oxide.
  • Preferred metal salts include salts of multivalent cations, for example aluminum acetate, aluminum chloride, calcium chloride, magnesium chloride, zinc chloride, aluminum nitrate, barium nitrate, calcium nitrate, magnesium nitrate, strontium nitrate and calcium fluoroborate.
  • Preferred glasses include borate glasses, phosphate glasses and fluoroaluminosilicate glasses.
  • acid reactive fillers are those that release fluoride.
  • Fluoride releasing glasses in addition to providing good handling and final composition properties as discussed above, provide the benefit of long-term release of fluoride in use, for example in the oral cavity. Fluoroaluminosilicate glasses are particularly preferred.
  • Suitable acid reactive fillers are also available from a variety of commercial sources familiar to those skilled in the art. For example, suitable fillers can be obtained from a number of commercially available glass ionomer cements, such as “GC Fuji LC” and “Kerr XR” ionomer cement. Mixtures of fillers can be used if desired.
  • the acid reactive filler can be subjected to a surface treatment. Suitable surface treatments include acid washing, treatment with phosphates, treatment with chelating agents such as tartaric acid, treatment with a silane or silanol coupling agent. Particularly preferred acid reactive fillers are silanol treated fluoroaluminosilicate glass fillers, as described in U.S. Pat. No. 5,332,429 the disclosure of which is expressly incorporated by reference herein.
  • the polymerizable component of the present compositions are compounds, which may be monomers, oligomers, or polymers, containing a polymerizable group. These polymerizable groups may be selected from free radically polymerizable groups, cationically polymerizable groups, or mixtures thereof Preferably, the polymerizable compound has a molecular weight of between about 100 to 5000, and more preferably, has a molecular weight between about 300 and 1000. Mixtures of both higher and lower molecular weight polymerizable materials are also contemplated as providing special benefits in handling properties and the physical properties of the ultimate cured material.
  • Preferred materials that provide the polymerizable component are the esters of acrylic or methacrylic acid.
  • these compounds are methyl acrylate, methyl methacrylate, ethyl acrylate, ethyl methacrylate, propyl acrylate, propyl methacrylate, isopropyl acrylate, isopropyl methacrylate, 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate (“HEMA”), hydroxypropyl acrylate, hydroxypropyl methacrylate, tetrahydrofurfuryl acrylate, tetrahydrofurfuryl methacrylate, glycidyl acrylate, glycidyl methacrylate, the diglycidyl methacrylate of bis-phenol A (“Bis-GMA”), glycerol mono- and di-acrylate, glycerol mono- and di-methacrylate, ethyleneglycol diacrylate, ethyleneglycol
  • polymerizable components can be substituted acryl amides and methacrylamides.
  • examples are acrylamide, methylene bis-acrylamide, methylene bis-methacrylamide, diacetone/acrylamide diacetone methacylamide, N-alkyl acrylamides and N-alkyl methacrylamides where alkyl is a lower hydrocarbyl unit.
  • Other suitable examples of polymerizable components are isopropenyl oxazoline, vinyl azalactone, vinyl pyrrolidone, styrene, divinylbenzene, urethane acrylates or methacrylates, epoxy acrylates or methacrylates and polyol acrylates or methacrylates.
  • the polymerizable component may be a cationically cured material, such as epoxy materials, oxetanes, oxolanes, cyclic acetals, lactams, lactones, and vinyl ethers or spirocyclic compounds containing O atoms in the rings.
  • a cationically cured material such as epoxy materials, oxetanes, oxolanes, cyclic acetals, lactams, lactones, and vinyl ethers or spirocyclic compounds containing O atoms in the rings.
  • the cationically polymerizable epoxy resins useful in the compositions of the invention comprise organic compounds having an oxirane ring, i.e.,
  • Such materials include monomeric epoxy compounds and epoxides of the polymeric type and can be aliphatic, cycloaliphatic, aromatic or heterocyclic. These materials generally have, on the average, at least 1 polymerizable epoxy group per molecule, and preferably at least about 1.5 polymerizable epoxy groups per molecule.
  • the polymeric epoxides include linear polymers having terminal epoxy groups (e.g., a diglycidyl ether of a polyoxyalkylene glycol), polymers having skeletal oxirane units (e.g., polybutadiene polyepoxide), and polymers having pendent epoxy groups (e.g., a glycidyl methacrylate polymer or copolymer).
  • the epoxides may be pure compounds or may be mixtures containing one, two, or more epoxy groups per molecule. The “average” number of epoxy groups per molecule is determined by dividing the total number of epoxy groups in epoxy-containing material by the total number of epoxy molecules present.
  • epoxy-containing materials may vary from low molecular weight monomeric materials to high molecular weight polymers and may vary greatly in the nature of their backbone and substituent groups.
  • the backbone may be of any type and substituent groups thereon can be any group that does not substantially interfere with cationic cure at room temperature.
  • permissible substituent groups include halogens, ester groups, ethers, sulfonate groups, siloxane groups, nitro groups, phosphate groups, and the like.
  • the molecular weight of the epoxy-containing materials may vary from about 58 to about 100,000 or more.
  • Useful epoxy-containing materials include those which contain cyclohexene oxide groups such as the epoxycyclohexanecarboxylates, typified by 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, 3,4-epoxy-2-methylcyclohexylmethyl-3,4-epoxy-2-methylcyclohexane carboxylate, and bis(3,4-epoxy-6-methylcyclohexylmethyl)adipate.
  • cyclohexene oxide groups such as the epoxycyclohexanecarboxylates, typified by 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, 3,4-epoxy-2-methylcyclohexylmethyl-3,4-epoxy-2-methylcyclohexane carboxylate, and bis(3,4-epoxy-6-methylcyclohexylmethyl)adipate.
  • epoxy-containing materials which are particularly useful in the practice of this invention include glycidyl ether monomers of the formula
  • R 1 is alkyl or aryl and n is an integer of 1 to 6.
  • examples are glycidyl ethers of polyhydric phenols obtained by reacting a polyhydric phenol with an excess of chlorohydrin such as epichlorohydrin (e.g., the diglycidyl ether of 2,2-bis-(2,3-epoxypropoxyphenol)-propane).
  • chlorohydrin such as epichlorohydrin
  • epoxides of this type which can be used in the practice of this invention are described in U.S. Pat. No. 3,018,262, incorporated herein by reference, and in “Handbook of Epoxy Resins” by Lee and Neville, McGraw-Hill Book Co., New York (1967).
  • epoxy resins which can be used in this invention.
  • epoxides which are readily available include octadecylene oxide, epichlorohydrin, styrene oxide, vinyl cyclohexene oxide, glycidol, glycidylmethacrylate, diglycidyl ether of Bisphenol A (e.g., those available under the trade designations “Epon 828”, “Epon 825”, “Epon 1004” and “Epon 1010” from Shell Chemical Co., “DER-331”, “DER-332”, and “DER-334”, from Dow Chemical Co.), vinylcyclohexene dioxide (e.g., “ERL-4206” from Union Carbide Corp.), 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexene carboxylate (e.g., “ERL4221” or “UVR 6110” or “UVR 6105” from Union Carbide Corp.
  • bis(3,4-epoxycyclohexyl)adipate e.g., “ERL-4299” or “UVR-6128”, from Union Carbide Corp.
  • 2-(3,4-epoxycyclohexyl-5,5-spiro-3,4-epoxy) cyclohexane-meta-dioxane e.g., “ERL-4234” from Union Carbide Corp.
  • vinylcyclohexene monoxide from Union Carbide Corp.
  • 1,2-epoxyhexadecane e.g., “UVR-6216” from Union Carbide Corp.
  • alkyl glycidyl ethers such as alkyl C 8 -C 10 glycidyl ether (e.g., “HELOXY Modifier 7” from Shell Chemical Co.), alkyl C 12 -C 14 glycidyl ether (e.g., “HELOXY Modifier 8” from Shell Chemical
  • Still other epoxy resins contain copolymers of acrylic acid esters or glycidol such as glycidylacrylate and glycidylmethacrylate with one or more copolymerizable vinyl compounds.
  • copolymers are 1:1 styrene-glycidylmethacrylate, 1:1 methylmethacrylate-glycidylacrylate and a 62.5:24:13.5 methylmethacrylate-ethyl acrylate-glycidylmethacrylate.
  • epoxy resins are well known and contain such epoxides as epichlorohydrins, e.g., epichlorohydrin; alkylene oxides, e.g., propylene oxide, styrene oxide; alkenyl oxides, e.g., butadiene oxide; glycidyl esters, e.g., ethyl glycidate.
  • epichlorohydrins e.g., epichlorohydrin
  • alkylene oxides e.g., propylene oxide, styrene oxide
  • alkenyl oxides e.g., butadiene oxide
  • glycidyl esters e.g., ethyl glycidate.
  • the polymers of the epoxy resin may optionally contain other functionalities that do not substantially interfere with cationic cure at room temperature.
  • Blends of various epoxy-containing materials are particularly contemplated in this invention.
  • examples of such blends include two or more molecular weight distributions of epoxy-containing compounds, such as low molecular weight (below 200), intermediate molecular weight (about 200 to 10,000) and higher molecular weight (above about 10,000).
  • the epoxy resin may contain a blend of epoxy-containing materials having different chemical nature, such as aliphatic and aromatic, or functionality, such as polar and non-polar.
  • Other cationically polymerizable polymers may additionally be incorporated.
  • Particularly preferred epoxy containing compositions also contain materials having hydroxyl functionality.
  • compositions of the invention contain one or more suitable polymerization initiators, so that the composition may be polymerized in use.
  • the initiator is selected such that it is capable of initiating the polymerization of the polymerizable material. That is, if the polymerizable material is a free radical polymerizable material, the initiator is a free-radical polymerization initiator. Likewise, if the polymerizable material is a cationically polymerizable material, the initiator is a cationic polymerization initiator.
  • one-part dental resin cement compositions are preferred, so that compositions using a photoinitiator system are preferred. However, in many applications of dental resin cements it is difficult if not impossible to expose the cement to the light of a curing lamp, so initiator systems that are capable of curing without light are very desirable as well.
  • compositions of the invention that are free-radically polymerized preferably contain one or more suitable photopolymerization initiators that act as a source of free radicals when activated.
  • suitable photopolymerization initiators can be used alone or in combination with one or more accelerators and/or sensitizers.
  • the photoinitiator should be capable of promoting free radical crosslinking of the ethylenically unsaturated moiety on exposure to light of a suitable wavelength and intensity. It also preferably is sufficiently shelf stable and free of undesirable coloration to permit its storage and use under typical dental conditions. Visible light photoinitiators are preferred.
  • the photoinitiator frequently can be used alone, but typically it is used in combination with a suitable donor compound or a suitable accelerator (for example, amines, peroxides, phosphorus compounds, ketones and alpha-diketone compounds).
  • Preferred visible light-induced initiators include camphorquinone (which typically is combined with a suitable hydrogen donor such as an amine), diaryliodonium simple or metal complex salts, chromophore-substituted halomethyl-s-triazines and halomethyl oxadiazoles.
  • Particularly preferred visible light-induced photoinitiators include combinations of an alpha-diketone, e.g., camphorquinone, and a diaryliodonium salt, e.g., diphenyliodonium chloride, bromide, iodide or hexafluorophosphate, with or without additional hydrogen donors (such as sodium benzene sulfinate, amines and amine alcohols).
  • Preferred ultraviolet light-induced polymerization initiators include ketones such as benzyl and benzoin, and acyloins and acyloin ethers.
  • Preferred commercially available ultraviolet light-induced polymerization initiators include 2,2-dimethoxy-2-phenylacetophenone (“IRGACURE 651”) and benzoin methyl ether (2-methoxy-2-phenylacetophenone), both from Ciba-Geigy Corp.
  • the photoinitiator should be present in an amount sufficient to provide the desired rate of photopolymerization. This amount will be dependent in part on the light source, the thickness of the layer to be exposed to radiant energy, and the extinction coefficient of the photoinitiator. Typically, the photoinitiator components will be present at a total weight of about 0.01 to about 5%, more preferably from about 0.1 to about 5%, based on the total weight of the composition.
  • compositions of the present invention may alternatively incorporate a mode of initiation of the polymerization reaction to initiate a crosslinking reaction without the need to expose the system to visible light.
  • a preferred alternative mode for initiation of the polymerization reaction is the incorporation of an oxidizing agent and a reducing agent as a redox catalyst system to enable the dental composition to cure via a redox reaction.
  • Various redox systems is described in U.S. Pat. No. 5,154,762, the disclosure of which is expressly incorporated herein by reference.
  • the oxidizing agent should react with or otherwise cooperate with the reducing agent to produce free radicals capable of initiating polymerization of the ethylenically unsaturated moiety.
  • the oxidizing agent and the reducing agent preferably are sufficiently shelf stable and free of undesirable coloration to permit their storage and use under typical dental conditions.
  • the oxidizing agent and the reducing agent should also preferably be sufficiently soluble and present in an amount sufficient to permit an adequate free radical reaction rate. This can be evaluated by combining the ethylenically unsaturated moiety, the oxidizing agent and the reducing agent and observing whether or not a hardened mass is obtained.
  • Suitable oxidizing agents include persulfates such as sodium, potassium, ammonium and alkyl ammonium persulfates, benzoyl peroxide, hydroperoxides such as cumene hydroperoxide, tert-butyl hydroperoxide, tert-amyl hydroperoxide and 2,5-dihydroperoxy-2,5-dimethylhexane, salts of cobalt (III) and iron (III), hydroxylamine, perboric acid and its salts, salts of a permanganate anion, and combinations thereof Hydrogen peroxide can also be used, although it may, in some instances, interfere with the photoinitiator, if one is present.
  • the oxidizing agent may optionally be provided in an encapsulated form as described in U.S. Pat. No. 5,154,762.
  • Preferred reducing agents include amines (and preferably aromatic amines), ascorbic acid, metal complexed ascorbic acid, cobalt (II) chloride, ferrous chloride, ferrous sulfate, hydrazine, hydroxylamine, oxalic acid, thiourea and salts of a dithionite, thiosulfate, benzene sulfinate, or sulfite anion.
  • redox initiator systems When redox initiator systems are used to photoinitiator systems, because care must be taken to keep the reducing agent from reacting with the oxidizing agent before polymerization is desired. Generally, the use of a redox system necessitates providing the material in a two-part format.
  • suitable initiators include salts that are capable of generating cations such as the diaryliodonium, triarylsulfonium and aryldiazonium salts.
  • Use of electronic donors or peroxides in such systems are also useful for enhancing rate of cure and depth of cure.
  • Simultaneous photoinitiation of cationic and free radical groups may be afforded by, for example, onium salts or organometallic compounds in combination with or without oxidizing agents.
  • Organometallic compounds can be selected from compounds that undergo sigma bond cleavage upon photolysis. The sigma bond is usually a metal-metal bond. Examples of suitable organometallic compounds include [Co Fe(Co) 2 ] 2 , Mn(CO) 10 , and Mn 2 (CO) 10 , in combination with iodonium salts and peroxides.
  • compositions of the invention can contain adjuvants such as cosolvents, pigments, inhibitors, accelerators, surfactants, colorants, medicaments and other ingredients that will be apparent to those skilled in the art.
  • adjuvants such as cosolvents, pigments, inhibitors, accelerators, surfactants, colorants, medicaments and other ingredients that will be apparent to those skilled in the art.
  • the compositions may contain stabilizers.
  • the fluoride-releasing materials may also be provided, which may be naturally occurring or synthetic fluoride minerals, fluoride glass such as fluoroaluminosilicate glass, simple and complex inorganic fluoride salts, simple and complex organic fluoride salts or combinations thereof.
  • fluoride sources can be treated with surface treatment agents.
  • fluoride-releasing material examples include fluoroaluminosilicate glasses described in U.S. Pat. No 4,3814,717, which may be optionally treated as described in U.S. Pat. No. 5,332,429, the disclosures of which are both incorporated by reference herein.
  • the dental materials of the present invention may be manufactured by mixing the filler, polymerizable resin, and handling modifier together. It may be preferable to mix the polymerizable resin and the handling modifier together first, followed by addition of the filler. It may be desirable to provide heat or to utilize other mixing techniques to ensure complete mixing of the modifier in the polymerizable resin, provided that the handling modifier must eventually be dispersed in the polymerizable resin at 25° C. If the initial mixture is found to have insufficient viscosity, more handling modifier and/or filler is added to provide the correct initial viscosity.
  • Commercially available cements may be modified in accordance with the present invention by adding handling modifier as defined herein and reducing the amount of filler if needed, thereby imparting the desired reverse rate viscosity curve.
  • the resin cements of the present invention may be used to place a number of materials, such as dental restoratives or prefabricated prosthetic devices.
  • prefabricated prosthetic devices include crowns, bridges, veneers, inlays, onlays, posts, pins, and the like.
  • restoratives include dental composites and amalgams.
  • a hard oral surface is any surface found in the oral environment suitable for bonding to, including enamel and dentin surfaces of the tooth, and any preexisting appliances or other structure in the oral environment, such as crowns, bridges, previously placed restoratives, or the like.
  • a prepared surface is one where the surface has been cleaned and, if necessary, drilled, abraded or otherwise prepared for subsequent adhesion thereto. In the context of the present invention, the step of surface preparation does not include acid etching of the surface.
  • a method of placing a prefabricated prosthetic device comprises a) preparing an oral surface, b) applying a dental resin cement of the present invention to a device, c) seating the device on the prepared oral surface, and d) cleaning off the excess resin cement from the margin between said oral surface and said device.
  • a method of adhering a direct restorative material comprises a) preparing an oral surface, b) applying a dental resin cement of the present invention to said prepared oral surface, and c) placing a direct restorative material on said cement applied to the prepared oral surface.
  • a method of adhering to a hard oral surface comprises, a) etching said oral surface, b) applying an adhesive composition comprising polymerizable monomer and polymerization initiator to said etched oral surface, c) causing said adhesive composition to polymerize on said surface, d) applying a resin cement of the present invention to said adhesive treated surface, and e) causing said resin cement to polymerize.
  • prefabricated prosthetic devices may be strongly adhered to a hard oral surface by a) etching said oral surface, b) applying an adhesive composition comprising polymerizable monomer and polymerization initiator to said etched oral surface, c) causing said adhesive composition to polymerize on said surface, d) applying a resin cement of the present invention to said prefabricated prosthetic device, e) seating the device on the prepared oral surface, and f) cleaning off the excess resin cement from the margin between said oral surface and said device.
  • FIG. 1 shows a Viscosity vs Shear Rate Curve of a composition of the present invention.
  • Curve A shows the viscosity at increasing shear rate
  • Curve B shows the viscosity at decreasing shear rate.
  • A-174 silane (3.7 g) was added with stirring to 50 g of deionized water acidified to pH 3-3.3 by dropwise addition of trifluoroacetic acid.
  • the resultant mixture was stirred at about 25° C. for 1 hour at which time 95 g of fumed silica having a surface area of 40-50 m 2 /g (OX-50) were added to the mixture with continued stirring for 4 hours.
  • the slurry was poured into a plastic-lined tray and dried at 35° C. for 36 hours.
  • the silanol treated dried powder was sieved through a 74 micrometer mesh screen.
  • 1% of triflouroacetic acid is added as required to 32.47 parts of deionized water and stirred for 5 minutes to attain a target pH range of 3.20-3.50.
  • the slurry is dried, and the resulting cakes are crushed, dried, and screened through a 74 micron mesh screen.
  • zirconia silica filler of average particle size 0.6-0.9 micrometers is mixed with deionized water at a solution temperature of between 20-30° C., and the pH is adjusted to 3-3.3 with Trifluoroacetic acid (TFAA)(0.278 parts).
  • TFAA Trifluoroacetic acid
  • A-174 silane 11.14 parts is added to the slurry and the blend is mixed over 2 hours.
  • a calcium hydroxide (0.299 parts) water solution is added to the tank.
  • the filler is dried, crushed and screened through a 74 or 100 micron screen.
  • the cement formulation used consists of 3.75% 2 equivalents of isocyanatoethyl methacrylate reacted with polycaprolactone molecular weight 1250 g/mole (tone 0230, Union Carbide), 14.6% triethyleneglycol dimethacrylate, 14.6% Bis-GMA and 68% of a blend of 10% the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 17% Terathane (polytetrahydrofuran) 2900, 18% 2-hydroxyethyl methacrylate, 14.6% Bis-GMA and 65% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 32% 6 mole ethoxylated Bisphenol-A dimethacrylate and 68% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 3.75% polycaprolactonediol 1250 g/mole (TONE0230, Union Carbide), 14.6% triethyleneglycol dimethacrylate, 14.6% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 32% 6 mole ethoxylated Bisphenol-A dimethacrylate and 68% of a blend of 10% of the filler of Preparatory Example 1 and 900% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 3.75% 2 equivalents of isocyanatoethyl methacrylate reacted with polycaprolactonediol molecular weight 1250 g/mole (TONE0230, Union Carbide), 14.6% triethyleneglycol dimethacrylate, 14.6% Bis-GMA and 73% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation consists of 27% 6 mole ethoxylated Bisphenol-A dimethacrylate and 73% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation consists of 32% 6 mole ethoxylated Bisphenol-A dimethacrylate and 68% of the filler of Preparatory Example 3.
  • the cement formulation consists of 37% 6 mole ethoxylated Bisphenol-A dimethacrylate and 63% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation consists of 70% of polyethylene glycol 1000 g/mole (PEG) encapped with 1 equivalent of 2-hydroxyethyl methacrylate(HEMA) and 1 equivalent of toluene diisocyanate(TDI), 12.5% triethyleneglycol dimethacrylate, 12.5% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • PEG polyethylene glycol 1000 g/mole
  • HEMA 2-hydroxyethyl methacrylate
  • TDI toluene diisocyanate
  • Bis-GMA Bis-GMA
  • the cement formulation used consists of 4.5% polycaprolactonediol (TONE0230), 13.75% triethyleneglycol dimethacrylate, 13.75% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 4% polycaprolactonediol 3000 g/mole(TONE0260 Union Carbide), 14% triethyleneglycol dimethacrylate, 14% Bis-GNU and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 4% of a copolymer of bisphenol-A and epichlorohydrin1075 g/mole, 14.6% triethyleneglycol dimethacrylate, 14.6% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 4.5% 2 equivalents of isocyanatoethyl methacrylate reacted with polycaprolactonediol (TONE0230) g/mole, 11.25% triethyleneglycol dimethacrylate, 11.25% Bis-GMA and 73% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 1.5% N-polyvinylpyrrolidinone k2932 (International Specialty Products, Wayne, N.J.), 17.0% Bis-GMA, 15.25% 2-hydroxyethyl methacrylate and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 4.3% polycaprolactonediol molecular weight 3000 g/mole (TONE0260), 13.85% triethyleneglycol dimethacrylate, 13.85% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 29% of 6 mole Bis-EMA and 71% of the filler of Preparatory Example 2.
  • the cement formulation used consists of 4% polyethyleneglycol methyl ether 2000 g/mole, 14% Bis-GMA, 14% 2-hydroxyethyl methacrylate and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 4% polycaprolactonediol molecular (TONE 0240), 14% triethyleneglycol dimethacrylate, 14% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 30% 10 mole ethoxylated Bisphenol-A dimethacrylate, 1.5% triethyleneglycol dimethacrylate, and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 2% polycaprolactone molecular weight 3000 g/mole (TONE0260), 13.85% TRIETHYLENEGLYCOL DIMETHACRYLATE, 13.85% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 18% 2-hydroxy ethyl methacrylate, 43% of the filler of Preparatory Example 5, 22% of the filler of Preparatory Example 6, and 17% of a polymer of 2 equivalents of 2-phosphonooxy ethyl methacrylate and 1 equivalent of urethane (polytetrahydrofuran) 2900.
  • the cement formulation consists of 16% triethyleneglycol dimethacrylate, 16% 6 mole Bis-EMA and 68% of the filler of Preparatory Example 6.
  • the cement formulation consists of 32% 6-mole ethoxylated Bisphenol-A dimethacrylate (6 mole Bis-EMA), 25% of the filler of Preparatory Example 6 and 43% of the filler of Preparatory Example 5.
  • the cement formulation used consists of 4% hydroxyl endcapped polybutadiene 2800 g/mole, 14.6% triethyleneglycol dimethacrylate, 14.6% Bis-GMA and 68% of a blend of 10% of the filler of Preparatory Example 1 and 90% of the filler of Preparatory Example 4.
  • the cement formulation used consists of 4% 2 equivalents of isocyanatoethyl methacrylate reacted with polycaprolactone molecular weight 1250 g/mole, 14.6% triethyleneglycol dimethacrylate, 14.6% bis-GMA, 25% of the filler of Preparatory Example 6 and 45% of the filler of Preparatory Example 5.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dental Preparations (AREA)
US08/896,549 1997-07-17 1997-07-17 Dental resin cements having improved handling properties Expired - Lifetime US6506816B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US08/896,549 US6506816B1 (en) 1997-07-17 1997-07-17 Dental resin cements having improved handling properties
AU55161/98A AU5516198A (en) 1997-07-17 1997-12-03 Dental resin cements having improved handling properties
PCT/US1997/022182 WO1999003444A1 (en) 1997-07-17 1997-12-03 Dental resin cements having improved handling properties
EP97951546A EP0998252B1 (en) 1997-07-17 1997-12-03 Dental resin cements having improved handling properties
JP2000502747A JP2001510146A (ja) 1997-07-17 1997-12-03 取り扱い特性が改善された歯科用樹脂セメント
CA002295502A CA2295502A1 (en) 1997-07-17 1997-12-03 Dental resin cements having improved handling properties
US10/315,505 US6939900B2 (en) 1997-07-17 2002-12-10 Dental resin cements having improved handling properties
JP2009192168A JP5080538B2 (ja) 1997-07-17 2009-08-21 取り扱い特性が改善された歯科用樹脂セメント

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/896,549 US6506816B1 (en) 1997-07-17 1997-07-17 Dental resin cements having improved handling properties

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/315,505 Continuation US6939900B2 (en) 1997-07-17 2002-12-10 Dental resin cements having improved handling properties

Publications (1)

Publication Number Publication Date
US6506816B1 true US6506816B1 (en) 2003-01-14

Family

ID=25406407

Family Applications (2)

Application Number Title Priority Date Filing Date
US08/896,549 Expired - Lifetime US6506816B1 (en) 1997-07-17 1997-07-17 Dental resin cements having improved handling properties
US10/315,505 Expired - Fee Related US6939900B2 (en) 1997-07-17 2002-12-10 Dental resin cements having improved handling properties

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/315,505 Expired - Fee Related US6939900B2 (en) 1997-07-17 2002-12-10 Dental resin cements having improved handling properties

Country Status (6)

Country Link
US (2) US6506816B1 (el)
EP (1) EP0998252B1 (el)
JP (2) JP2001510146A (el)
AU (1) AU5516198A (el)
CA (1) CA2295502A1 (el)
WO (1) WO1999003444A1 (el)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114554A1 (en) * 1997-07-17 2003-06-19 3M Innovative Properties Company Dental resin cements having improved handling properties
US20030114553A1 (en) * 2001-08-15 2003-06-19 Naimul Karim Hardenable self-supporting structures and methods
US6730715B2 (en) * 2001-07-06 2004-05-04 Pentron Clinical Technologies, Llc Dental restorative composition, dental restoration, and a method of use thereof
US20040206932A1 (en) * 2002-12-30 2004-10-21 Abuelyaman Ahmed S. Compositions including polymerizable bisphosphonic acids and methods
US20050042577A1 (en) * 2003-08-19 2005-02-24 Kvitrud James R. Dental crown forms and methods
US20050042576A1 (en) * 2003-08-19 2005-02-24 Oxman Joel D. Dental article forms and methods
US20050040551A1 (en) * 2003-08-19 2005-02-24 Biegler Robert M. Hardenable dental article and method of manufacturing the same
US20050113480A1 (en) * 2003-11-21 2005-05-26 Gc Corporation Photopolymerization type dental surface coating material
US20050165129A1 (en) * 2003-08-29 2005-07-28 Norbert Moszner Dental coating materials
US20050176844A1 (en) * 2003-08-12 2005-08-11 Aasen Steven M. Self-etching emulsion dental compositions and methods
US20050197422A1 (en) * 2004-03-03 2005-09-08 Mayadunne Roshan T.A. Biocompatible polymer compositions for dual or multi staged curing
US6953832B2 (en) * 2001-01-15 2005-10-11 Ivoclar Vivadent Ag Dental materials based on polyfunctional amides
US20060069181A1 (en) * 2004-09-24 2006-03-30 3M Espe Ag Dental adhesive composition
US20070142498A1 (en) * 2005-12-20 2007-06-21 Brennan Joan V Dental compositions including thermally responsive additives, and the use thereof
US20070141524A1 (en) * 2005-12-20 2007-06-21 Brennan Joan V Dental compositions including radiation-to-heat converters, and the use thereof
US20070142497A1 (en) * 2005-12-20 2007-06-21 Kalgutkar Rajdeep S Methods for reducing bond strengths, dental compositions, and the use thereof
US20070196792A1 (en) * 2006-02-21 2007-08-23 Johnson Jason K Prefabricated Dental Crowns
US20070215275A1 (en) * 2002-06-27 2007-09-20 Nitto Denko Corporation Protective film
US20070248927A1 (en) * 2004-08-11 2007-10-25 Thomas Luchterhandt Self-Adhesive Compositions Including a Plurality of Acidic Compouns
WO2008033911A2 (en) 2006-09-13 2008-03-20 3M Innovative Properties Company Dental compositions including organogelators, products, and methods
US20080299519A1 (en) * 2004-07-08 2008-12-04 Craig Bradley D Dental Methods, Compositions, and Kits Including Acid-Sensitive Dyes
US20090239969A1 (en) * 2004-08-10 2009-09-24 Scientific Pharmaceuticals, Inc Dental prosthetics comprising curable acrylate polymer compositions and methods of their use
US20090286205A1 (en) * 2006-02-21 2009-11-19 Johnson Jason K Prefabricated Dental Crowns
US20100331334A1 (en) * 2007-01-19 2010-12-30 Koh Yung-Hyo Inhibitors of mek
US8026296B2 (en) 2005-12-20 2011-09-27 3M Innovative Properties Company Dental compositions including a thermally labile component, and the use thereof
WO2012112350A2 (en) 2011-02-15 2012-08-23 3M Innovative Properties Company Dental compositions comprising ethylenically unsaturated addition-fragmentation agent
US20130210959A1 (en) * 2010-10-27 2013-08-15 3M Innovative Properties Company Dental compositions comprising semi-crystalline resin and nanocluster filler
US8987352B1 (en) * 2009-12-23 2015-03-24 Nei Corporation Phase separated self-healing polymer coatings
US9943465B2 (en) 2006-12-13 2018-04-17 3M Innovative Properties Company Methods of using a dental composition having an acidic component and a photobleachable dye
US11793731B2 (en) 2017-12-19 2023-10-24 3M Innovative Properties Company Multi-part dental composition having staged viscosity prior to hardening

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
DE19937091A1 (de) * 1999-08-06 2001-02-22 Espe Dental Ag Adhäsivsysteme II
DE19937093A1 (de) * 1999-08-06 2001-02-08 Espe Dental Ag Adhäsivsysteme III
EP1413283B1 (en) * 2000-08-11 2017-09-20 DENTSPLY International Inc. Dental compositions comprising bisacrylamides and use thereof
DE60125374T3 (de) * 2000-08-11 2015-03-19 Dentsply International Inc. Bisacrylamid enthaltende dentalmassen und deren verwendung
US6818682B2 (en) * 2001-04-20 2004-11-16 3M Innovative Properties Co Multi-part dental compositions and kits
US7589132B2 (en) * 2001-05-01 2009-09-15 Pentron Clinical Technologies, Llc Dental resins, dental composite materials, and method of manufacture thereof
US7226960B2 (en) * 2001-05-10 2007-06-05 Pentron Clinical Technologies, Llc Self-etching primer adhesive and method of use therefor
US6982288B2 (en) 2002-04-12 2006-01-03 3M Innovative Properties Company Medical compositions containing an ionic salt, kits, and methods
BRPI0416068A (pt) * 2003-10-29 2007-01-02 Doxa Ab sistema de duas etapas para melhorar as caracterìsticas inicial e final de um biomaterial
US7700667B2 (en) * 2004-01-29 2010-04-20 Pentron Clinical Technologies, Llc Dental resin composition, method of manufacture, and method of use thereof
JP4827145B2 (ja) * 2004-07-14 2011-11-30 スリーエム イノベイティブ プロパティズ カンパニー オキシランモノマーを含有する歯科用組成物
US7498367B2 (en) * 2005-02-21 2009-03-03 Kerr Corporation Acid-tolerant dental composition
US7947759B2 (en) * 2005-08-08 2011-05-24 Angstrom Medica Cement products and methods of making and using the same
AU2006290842A1 (en) * 2005-09-14 2007-03-22 Danville Materials, Inc. Composite paste for dental prostheses
US8664294B2 (en) * 2006-02-23 2014-03-04 Pentron Clinical Technologies, Llc Self etch all purpose dental cement composition and method of use thereof
US20080242761A1 (en) * 2006-02-23 2008-10-02 Weitao Jia Self etch all purpose dental compositions, method of manufacture, and method of use thereof
US7906564B2 (en) * 2006-02-23 2011-03-15 Pentron Clinical Technologies, Llc Self etch all purpose dental cement composition, method of manufacture, and method of use thereof
WO2008068862A1 (ja) 2006-12-06 2008-06-12 Kabushiki Kaisha Shofu 歯科用樹脂系セメント組成物
US9289358B2 (en) * 2007-02-28 2016-03-22 Ultradent Products, Inc. Resin reinforced zinc polycarboxylate temporary cement compositions and related kits and methods
EP2192886B1 (en) 2007-08-28 2017-12-20 Pioneer Surgical Technology, Inc. Cement products and methods of making and using the same
DE102007050762B3 (de) * 2007-10-22 2009-05-07 Heraeus Medical Gmbh Pastenförmiger Polymethylmethacrylat-Knochenzement und seine Verwendung
US8053490B2 (en) * 2009-05-18 2011-11-08 Pentron Clinical Technologies, Llc Pre-treated acid-reactive fillers and their use in dental applications
WO2011104704A2 (en) * 2010-02-24 2011-09-01 Corona Dent. Ltd. Long lasting dental restorations and methods for preparation thereof
EP2404590B1 (de) * 2010-07-08 2019-06-12 Ivoclar Vivadent AG Lichthärtende Keramikschlicker für die stereolithographische Herstellung von hochfesten Keramiken
EP2412361A1 (en) 2010-07-29 2012-02-01 3M Innovative Properties Company Kit of parts, method of producing and use thereof
US9402697B2 (en) 2012-04-19 2016-08-02 Research Triangle Institute Modification of ceramic surfaces
EP3522817B1 (en) 2016-10-05 2021-12-08 3M Innovative Properties Company Application device with redox initiator system, method of production and use thereof

Citations (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018262A (en) 1957-05-01 1962-01-23 Shell Oil Co Curing polyepoxides with certain metal salts of inorganic acids
US3117099A (en) 1959-12-24 1964-01-07 Union Carbide Corp Curable mixtures comprising epoxide compositions and divalent tin salts
US3513123A (en) 1967-10-11 1970-05-19 Dentsply Int Inc Adhesive dental filling
US3655605A (en) 1966-12-30 1972-04-11 Nat Res Dev Surgical cements from zinc oxide and aqueous poly(acrylic acid)
US3814717A (en) 1970-12-04 1974-06-04 Dental Materials Section Labor Poly(carboxylic acid)-fluoroalumino-silicate glass surgical cement
US4143018A (en) 1974-10-24 1979-03-06 National Research Development Corporation Cements
US4209434A (en) 1972-04-18 1980-06-24 National Research Development Corporation Dental cement containing poly(carboxylic acid), chelating agent and glass cement powder
US4360605A (en) 1979-08-13 1982-11-23 Espe Fabrik Pharmazeutischer Praparate Gmbh Mixing component for dental glass ionomer cements
US4376835A (en) 1979-07-18 1983-03-15 Espe Fabrik Pharmazeutischer Praparate Gmbh Calcium depleted aluminum fluorosilicate glass powder for use in dental or bone cements
US4411625A (en) * 1980-08-29 1983-10-25 Dentsply Research & Development Corp. Broad spectrum light curable dental compositions
US4503169A (en) 1984-04-19 1985-03-05 Minnesota Mining And Manufacturing Company Radiopaque, low visual opacity dental composites containing non-vitreous microparticles
US4540723A (en) * 1984-05-16 1985-09-10 J&J Dental Products Inc. Dental restorative composition containing monofunctional monomer and diolefinically unsaturated monomer
US4615665A (en) * 1983-05-06 1986-10-07 Dentsply International Inc. Method for making dental prosthetic device with oxygen barrier layer and visible light irradiation to cure polymer
US4648844A (en) * 1985-03-22 1987-03-10 Kuraray Co., Ltd. Dental lining composition
US4695251A (en) 1980-04-07 1987-09-22 Minnesota Mining And Manufacturing Company Orthodontic bracket adhesive and abrasive for removal thereof
US4746686A (en) * 1987-04-17 1988-05-24 Kerr Manufacturing Company Visible light activated cavity liner
US4792577A (en) 1987-07-16 1988-12-20 Johnson & Johnson Consumer Products, Inc. Stain-resistant no-mix orthodontic adhesive
US4859716A (en) * 1987-11-06 1989-08-22 Den-Mat Corporation Microfilled dental composite and method for making it
US5034433A (en) * 1990-04-10 1991-07-23 Essential Dental Systems, Inc. Composite dental cement composition containing titanium
EP0438629A2 (de) * 1990-01-24 1991-07-31 Heraeus Kulzer GmbH Polymerisierbare Mischung und ihre Verwendung
US5154762A (en) 1991-05-31 1992-10-13 Minnesota Mining And Manufacturing Company Universal water-based medical and dental cement
EP0533434A1 (en) 1991-09-20 1993-03-24 Minnesota Mining And Manufacturing Company Aesthetic, opalescent cold-polymerizable dental materials
US5204398A (en) * 1992-03-17 1993-04-20 Essential Dental Systems, Inc. Composite dental cement composition containing a lanthanide series compound
US5332429A (en) 1991-05-31 1994-07-26 Minnesota Mining And Manufacturing Company Method for treating fluoroaluminosilicate glass
US5403188A (en) * 1990-02-23 1995-04-04 Oxman; Joel D. Dental crowns and bridges from semi-thermoplastic molding compositions having heat-stable custom shape memory
US5530038A (en) * 1993-08-02 1996-06-25 Sun Medical Co., Ltd. Primer composition and curable composition
WO1997018792A1 (en) 1995-11-17 1997-05-29 Minnesota Mining And Manufacturing Company Fluoride-releasing compositions
US5709548A (en) * 1990-02-23 1998-01-20 Minnesota Mining And Manufacturing Company Dental crown liner composition and methods of preparing provisional applications
US5753781A (en) * 1990-02-23 1998-05-19 Minnesota Mining And Manufacturing Company Blended polycaprolactone thermoplastic molding composition
US5965632A (en) * 1997-06-20 1999-10-12 Scientific Pharmaceuticals Inc. Dental cement compositions
US6057383A (en) * 1996-06-18 2000-05-02 Ivoclar Ag Dental material based on polymerizable waxes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3468833B2 (ja) * 1994-04-28 2003-11-17 サンメディカル株式会社 歯科用硬化性組成物の製品キット
JP4002996B2 (ja) * 1995-06-15 2007-11-07 スリーエム カンパニー ガラスイオノマーセメントを使用して暫間義歯装置を合着する方法およびそのためのキット
US6391286B1 (en) * 1995-11-17 2002-05-21 3M Innovative Properties Company Use of metallofluorocomplexes for dental compositions
US6506816B1 (en) * 1997-07-17 2003-01-14 3M Innovative Properties Company Dental resin cements having improved handling properties

Patent Citations (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018262A (en) 1957-05-01 1962-01-23 Shell Oil Co Curing polyepoxides with certain metal salts of inorganic acids
US3117099A (en) 1959-12-24 1964-01-07 Union Carbide Corp Curable mixtures comprising epoxide compositions and divalent tin salts
US3655605A (en) 1966-12-30 1972-04-11 Nat Res Dev Surgical cements from zinc oxide and aqueous poly(acrylic acid)
US3513123A (en) 1967-10-11 1970-05-19 Dentsply Int Inc Adhesive dental filling
US3814717A (en) 1970-12-04 1974-06-04 Dental Materials Section Labor Poly(carboxylic acid)-fluoroalumino-silicate glass surgical cement
US4209434A (en) 1972-04-18 1980-06-24 National Research Development Corporation Dental cement containing poly(carboxylic acid), chelating agent and glass cement powder
US4143018A (en) 1974-10-24 1979-03-06 National Research Development Corporation Cements
US4376835A (en) 1979-07-18 1983-03-15 Espe Fabrik Pharmazeutischer Praparate Gmbh Calcium depleted aluminum fluorosilicate glass powder for use in dental or bone cements
US4360605A (en) 1979-08-13 1982-11-23 Espe Fabrik Pharmazeutischer Praparate Gmbh Mixing component for dental glass ionomer cements
US4695251A (en) 1980-04-07 1987-09-22 Minnesota Mining And Manufacturing Company Orthodontic bracket adhesive and abrasive for removal thereof
US4411625A (en) * 1980-08-29 1983-10-25 Dentsply Research & Development Corp. Broad spectrum light curable dental compositions
US4615665A (en) * 1983-05-06 1986-10-07 Dentsply International Inc. Method for making dental prosthetic device with oxygen barrier layer and visible light irradiation to cure polymer
US4503169A (en) 1984-04-19 1985-03-05 Minnesota Mining And Manufacturing Company Radiopaque, low visual opacity dental composites containing non-vitreous microparticles
US4540723A (en) * 1984-05-16 1985-09-10 J&J Dental Products Inc. Dental restorative composition containing monofunctional monomer and diolefinically unsaturated monomer
US4648844A (en) * 1985-03-22 1987-03-10 Kuraray Co., Ltd. Dental lining composition
US4746686A (en) * 1987-04-17 1988-05-24 Kerr Manufacturing Company Visible light activated cavity liner
US4792577A (en) 1987-07-16 1988-12-20 Johnson & Johnson Consumer Products, Inc. Stain-resistant no-mix orthodontic adhesive
US4859716A (en) * 1987-11-06 1989-08-22 Den-Mat Corporation Microfilled dental composite and method for making it
EP0438629A2 (de) * 1990-01-24 1991-07-31 Heraeus Kulzer GmbH Polymerisierbare Mischung und ihre Verwendung
US5403188A (en) * 1990-02-23 1995-04-04 Oxman; Joel D. Dental crowns and bridges from semi-thermoplastic molding compositions having heat-stable custom shape memory
US5753781A (en) * 1990-02-23 1998-05-19 Minnesota Mining And Manufacturing Company Blended polycaprolactone thermoplastic molding composition
US5709548A (en) * 1990-02-23 1998-01-20 Minnesota Mining And Manufacturing Company Dental crown liner composition and methods of preparing provisional applications
US5034433A (en) * 1990-04-10 1991-07-23 Essential Dental Systems, Inc. Composite dental cement composition containing titanium
US5154762A (en) 1991-05-31 1992-10-13 Minnesota Mining And Manufacturing Company Universal water-based medical and dental cement
US5332429A (en) 1991-05-31 1994-07-26 Minnesota Mining And Manufacturing Company Method for treating fluoroaluminosilicate glass
EP0533434A1 (en) 1991-09-20 1993-03-24 Minnesota Mining And Manufacturing Company Aesthetic, opalescent cold-polymerizable dental materials
US5204398A (en) * 1992-03-17 1993-04-20 Essential Dental Systems, Inc. Composite dental cement composition containing a lanthanide series compound
US5530038A (en) * 1993-08-02 1996-06-25 Sun Medical Co., Ltd. Primer composition and curable composition
WO1997018792A1 (en) 1995-11-17 1997-05-29 Minnesota Mining And Manufacturing Company Fluoride-releasing compositions
US6057383A (en) * 1996-06-18 2000-05-02 Ivoclar Ag Dental material based on polymerizable waxes
US5965632A (en) * 1997-06-20 1999-10-12 Scientific Pharmaceuticals Inc. Dental cement compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Handbook of Epoxy Resins by Lee and Neville, McGraw-Hill Book Co., New York (1967).
International Search Report.

Cited By (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114554A1 (en) * 1997-07-17 2003-06-19 3M Innovative Properties Company Dental resin cements having improved handling properties
US6939900B2 (en) * 1997-07-17 2005-09-06 3M Innovative Properties Company Dental resin cements having improved handling properties
US6953832B2 (en) * 2001-01-15 2005-10-11 Ivoclar Vivadent Ag Dental materials based on polyfunctional amides
US6730715B2 (en) * 2001-07-06 2004-05-04 Pentron Clinical Technologies, Llc Dental restorative composition, dental restoration, and a method of use thereof
US20030114553A1 (en) * 2001-08-15 2003-06-19 Naimul Karim Hardenable self-supporting structures and methods
US20090032989A1 (en) * 2001-08-15 2009-02-05 3M Innovative Properties Company Hardenable self-supporting structures and methods
US7816423B2 (en) 2001-08-15 2010-10-19 3M Innovative Properties Company Hardenable self-supporting structures and methods
US7674850B2 (en) * 2001-08-15 2010-03-09 3M Innovative Properties Company Hardenable self-supporting structures and methods
US20070215275A1 (en) * 2002-06-27 2007-09-20 Nitto Denko Corporation Protective film
US20040206932A1 (en) * 2002-12-30 2004-10-21 Abuelyaman Ahmed S. Compositions including polymerizable bisphosphonic acids and methods
US8404144B2 (en) 2002-12-30 2013-03-26 3M Innovative Properties Company Compositions including polymerizable bisphosphonic acids and methods
US20090075239A1 (en) * 2002-12-30 2009-03-19 3M Innovative Properties Company Compositions including polymerizable bisphosphonic acids and methods
US7699605B2 (en) 2003-08-12 2010-04-20 3M Espe Ag Self-etching emulsion dental compositions and methods
US7449499B2 (en) 2003-08-12 2008-11-11 3M Innovative Properties Company Self-etching dental compositions and methods
US20050175965A1 (en) * 2003-08-12 2005-08-11 Craig Bradley D. Self-etching dental compositions and methods
US20090035728A1 (en) * 2003-08-12 2009-02-05 3M Innovative Properties Company Self-etching emulsion dental compositions and methods
US20050176844A1 (en) * 2003-08-12 2005-08-11 Aasen Steven M. Self-etching emulsion dental compositions and methods
US20090011388A1 (en) * 2003-08-12 2009-01-08 3M Innovative Properties Company Self-etching dental compositions and methods
US8029286B2 (en) 2003-08-12 2011-10-04 3M Innovative Properties Company Self-etching dental compositions and methods
US7452924B2 (en) 2003-08-12 2008-11-18 3M Espe Ag Self-etching emulsion dental compositions and methods
US7632098B2 (en) 2003-08-12 2009-12-15 3M Innovative Properties Company Self-adhesive dental compositions and methods
US20050040551A1 (en) * 2003-08-19 2005-02-24 Biegler Robert M. Hardenable dental article and method of manufacturing the same
US20100330524A1 (en) * 2003-08-19 2010-12-30 3M Innovative Properties Company Hardenable dental article and method of manufacturing the same
US20100021868A1 (en) * 2003-08-19 2010-01-28 3M Innovative Properties Company Dental crown forms and methods
US20050042576A1 (en) * 2003-08-19 2005-02-24 Oxman Joel D. Dental article forms and methods
US8136657B2 (en) 2003-08-19 2012-03-20 3M Innovative Properties Company Packaged hardenable dental article
US7811486B2 (en) 2003-08-19 2010-10-12 3M Innovative Properties Company Method of manufacturing a hardenable dental article
US20050042577A1 (en) * 2003-08-19 2005-02-24 Kvitrud James R. Dental crown forms and methods
US20050165129A1 (en) * 2003-08-29 2005-07-28 Norbert Moszner Dental coating materials
US7495037B2 (en) 2003-08-29 2009-02-24 Ivoclar Vivadent Ag Dental coating materials
US20050113480A1 (en) * 2003-11-21 2005-05-26 Gc Corporation Photopolymerization type dental surface coating material
US8729202B2 (en) * 2004-03-03 2014-05-20 Polynovo Biomaterials Pty Limited Biocompatible polymer compositions for dual or multi staged curing
US20050197422A1 (en) * 2004-03-03 2005-09-08 Mayadunne Roshan T.A. Biocompatible polymer compositions for dual or multi staged curing
US20080299519A1 (en) * 2004-07-08 2008-12-04 Craig Bradley D Dental Methods, Compositions, and Kits Including Acid-Sensitive Dyes
US8465284B2 (en) 2004-07-08 2013-06-18 3M Innovative Properties Company Dental methods, compositions, and kits including acid-sensitive dyes
US20090239969A1 (en) * 2004-08-10 2009-09-24 Scientific Pharmaceuticals, Inc Dental prosthetics comprising curable acrylate polymer compositions and methods of their use
US20070248927A1 (en) * 2004-08-11 2007-10-25 Thomas Luchterhandt Self-Adhesive Compositions Including a Plurality of Acidic Compouns
US8722760B2 (en) 2004-08-11 2014-05-13 3M Innovative Properties Company Self-adhesive compositions including a plurality of acidic compounds
US20060069181A1 (en) * 2004-09-24 2006-03-30 3M Espe Ag Dental adhesive composition
US7896650B2 (en) 2005-12-20 2011-03-01 3M Innovative Properties Company Dental compositions including radiation-to-heat converters, and the use thereof
US20070141524A1 (en) * 2005-12-20 2007-06-21 Brennan Joan V Dental compositions including radiation-to-heat converters, and the use thereof
US7776940B2 (en) 2005-12-20 2010-08-17 3M Innovative Properties Company Methods for reducing bond strengths, dental compositions, and the use thereof
US8026296B2 (en) 2005-12-20 2011-09-27 3M Innovative Properties Company Dental compositions including a thermally labile component, and the use thereof
US20070142498A1 (en) * 2005-12-20 2007-06-21 Brennan Joan V Dental compositions including thermally responsive additives, and the use thereof
US20070142497A1 (en) * 2005-12-20 2007-06-21 Kalgutkar Rajdeep S Methods for reducing bond strengths, dental compositions, and the use thereof
US20090286205A1 (en) * 2006-02-21 2009-11-19 Johnson Jason K Prefabricated Dental Crowns
US20070196792A1 (en) * 2006-02-21 2007-08-23 Johnson Jason K Prefabricated Dental Crowns
EP2377507A2 (en) 2006-09-13 2011-10-19 3M Innovative Properties Company Dental compositions including organogelators, products, and methods
US8445558B2 (en) 2006-09-13 2013-05-21 3M Innovative Properties Company Dental compositions including organogelators, products, and methods
US8552086B2 (en) 2006-09-13 2013-10-08 3M Innovative Properties Company Dental compositions including organogelators, products, and methods
US20090305196A1 (en) * 2006-09-13 2009-12-10 Naimul Karim Dental compositions including organogelators, products, and methods
WO2008033911A2 (en) 2006-09-13 2008-03-20 3M Innovative Properties Company Dental compositions including organogelators, products, and methods
US9943465B2 (en) 2006-12-13 2018-04-17 3M Innovative Properties Company Methods of using a dental composition having an acidic component and a photobleachable dye
US20100331334A1 (en) * 2007-01-19 2010-12-30 Koh Yung-Hyo Inhibitors of mek
US8987352B1 (en) * 2009-12-23 2015-03-24 Nei Corporation Phase separated self-healing polymer coatings
US20130210959A1 (en) * 2010-10-27 2013-08-15 3M Innovative Properties Company Dental compositions comprising semi-crystalline resin and nanocluster filler
US8906981B2 (en) * 2010-10-27 2014-12-09 3M Innovative Properties Company Dental compositions comprising semi-crystalline resin and nanocluster filler
US9056043B2 (en) 2011-02-15 2015-06-16 3M Innovative Properties Company Dental compositions comprising ethylenically unsaturated addition-fragmentation agent
EP2965742A1 (en) 2011-02-15 2016-01-13 3M Innovative Properties Company of 3M Center Dental compositions comprising ethylenically unsaturated addition-fragmentation agent
US9320685B2 (en) 2011-02-15 2016-04-26 3M Innovative Properties Company Dental compositions comprising ethylenically unsaturated addition-fragmentation agent
WO2012112350A2 (en) 2011-02-15 2012-08-23 3M Innovative Properties Company Dental compositions comprising ethylenically unsaturated addition-fragmentation agent
US11793731B2 (en) 2017-12-19 2023-10-24 3M Innovative Properties Company Multi-part dental composition having staged viscosity prior to hardening

Also Published As

Publication number Publication date
AU5516198A (en) 1999-02-10
JP2001510146A (ja) 2001-07-31
JP2010031014A (ja) 2010-02-12
CA2295502A1 (en) 1999-01-28
WO1999003444A1 (en) 1999-01-28
EP0998252A1 (en) 2000-05-10
EP0998252B1 (en) 2012-01-18
US6939900B2 (en) 2005-09-06
JP5080538B2 (ja) 2012-11-21
US20030114554A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
US6506816B1 (en) Dental resin cements having improved handling properties
US6126922A (en) Fluorid-releasing compositions and compositions with improved rheology
JP4828796B2 (ja) イオン塩を含有する医用組成物
CN101035499B (zh) 包括多种酸性化合物的自粘合组合物
CN100558775C (zh) 包含可聚合还原剂的组合物、试剂盒及其制备方法
JPH0653647B2 (ja) 歯科修復用組成物
JP4986437B2 (ja) 歯科用硬化性組成物
JP2000159621A (ja) 歯科用光重合性組成物
EP0393617B1 (en) Dental adhesive composition
EP1498098B1 (en) Adhesive composition with decreased polarity upon polymerization
JP2813825B2 (ja) 二官能のアクリル酸エステル類あるいはメタクリル酸エステル類を含む歯科用組成物
JP2004352698A (ja) 歯科用組成物
JP3998737B2 (ja) 歯科用接着性組成物
JPH0374310A (ja) 歯科用接着剤組成物
JPS63162769A (ja) 裏装剤
US20020082317A1 (en) Dental adhesive compositions with desensitizing agents
JPS58173175A (ja) 歯科用接着剤
JPH0597620A (ja) 歯科用接着性組成物
JP3452613B2 (ja) フッ素イオン徐放性歯科用レジン組成物
JPH0588683B2 (el)
JPH0141601B2 (el)
JPH02252775A (ja) 光重合型接着剤組成物
JPS5928532B2 (ja) 歯科用接着組成物
JPH0662688B2 (ja) 光硬化性組成物
JPS6227403A (ja) 光硬化性組成物

Legal Events

Date Code Title Description
AS Assignment

Owner name: MINNESOTA MINING AND MANUFACTURING COMPANY, MINNES

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ARIO, PAULA D.;AASEN, STEVEN M.;HOLMES, BRIAN D.;REEL/FRAME:009105/0898

Effective date: 19971103

AS Assignment

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MINNESOTA MINING AND MANUFACTURING COMPANY;REEL/FRAME:010202/0843

Effective date: 19990824

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12